Business Description
Remed Co Ltd
ISIN : KR7302550009
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 98.35 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.75 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EPS without NRI Growth Rate | 4.5 | |||||
3-Year Book Growth Rate | 7.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.29 | |||||
9-Day RSI | 52.88 | |||||
14-Day RSI | 51.41 | |||||
6-1 Month Momentum % | -17.32 | |||||
12-1 Month Momentum % | 8.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.37 | |||||
Days Inventory | 215.55 | |||||
Days Sales Outstanding | 93.87 | |||||
Days Payable | 23.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 2.46 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.73 | |||||
Operating Margin % | -15.43 | |||||
Net Margin % | 4.3 | |||||
FCF Margin % | 14.05 | |||||
ROE % | 2.64 | |||||
ROA % | 1.13 | |||||
ROIC % | -1.36 | |||||
ROC (Joel Greenblatt) % | -2.65 | |||||
ROCE % | -2.14 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 107.82 | |||||
PE Ratio without NRI | 130.91 | |||||
PS Ratio | 4.67 | |||||
PB Ratio | 2.81 | |||||
Price-to-Tangible-Book | 2.83 | |||||
Price-to-Free-Cash-Flow | 33.25 | |||||
Price-to-Operating-Cash-Flow | 24.77 | |||||
EV-to-EBIT | -123.57 | |||||
EV-to-EBITDA | 571.57 | |||||
EV-to-Revenue | 5.23 | |||||
EV-to-FCF | 36.76 | |||||
Price-to-Graham-Number | 4.06 | |||||
Earnings Yield (Greenblatt) % | -0.81 | |||||
FCF Yield % | 3.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Remed Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 18,536.135 | ||
EPS (TTM) (â‚©) | 26.2 | ||
Beta | 1.27 | ||
Volatility % | 39.47 | ||
14-Day RSI | 51.41 | ||
14-Day ATR (â‚©) | 126.576056 | ||
20-Day SMA (â‚©) | 2794.25 | ||
12-1 Month Momentum % | 8.46 | ||
52-Week Range (â‚©) | 2320 - 16700 | ||
Shares Outstanding (Mil) | 30.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Remed Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Remed Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Remed Co Ltd Frequently Asked Questions
What is Remed Co Ltd(XKRX:302550)'s stock price today?
When is next earnings date of Remed Co Ltd(XKRX:302550)?
Does Remed Co Ltd(XKRX:302550) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |